Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an update.
Recordati S.p.A. has announced its corporate events calendar for 2025, detailing key dates for financial reporting and shareholder meetings. The company also outlines its dividend payment schedule for fiscal years 2024 and 2025, signaling planned financial activities and shareholder returns, which are subject to change based on market conditions.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with Italian roots dating back to a family pharmacy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, with operations spanning clinical development to marketing across 150 countries in EMEA, Americas, and APAC regions.
YTD Price Performance: 12.25%
Average Trading Volume: 22,981
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €11.56B
Learn more about REC stock on TipRanks’ Stock Analysis page.
